Charlie Silver, former Co-Founder/CEO of Mission Bio and currently Founding CEO at Ruby Bio discusses the scaling of life science startups, including: Consideration around platform build-out, market discovery, and early team and partnership building Prioritizing product opportunities in a crowded market Seed and early stage funding - lessons learned Nurturing and...
Read MoreAaron Fisher, Vice President, BroadOak Capital Partners discusses the criteria and development of portfolio startups and growth stage companies in life science tools and biopharma services markets. The macro/micro view of the market from a private equity perspective. ...
Read MoreIn this webinar, Aaron Josephson, former FDA Senior Policy Advisor, discusses: What is in the VALID Act, including key provisions like technology certification, third-party review, grandfathered and transitional tests, and other requirements for test developers How to participate in the implementation of the VALID Act, including the...
Read MoreCommercial Payer Strategies with Lon Castle of eviCore In this webinar, Lon Castle, MD, CMO, eviCore discusses: -Understanding the Technology Assessment process for tests -Learning how evidence evaluations differ for Medicare and Commercial payers -Preparing for potential payer presentations ...
Read MoreParadigms for MolDX Coverage with Gabe Bien-Willner In this webinar, Gabe Bien-Willner, Medical Director, MolDX discusses: - How to navigate policies of Medicare -How coverage is determined - Understanding the metrics Medicare uses to measure their tests ...
Read More